Showing results (1-10 of 6,218) with videos related to

Sort By:
Pageof 622
Diabetes, Obesity & Metabolism|December 8, 2022
Objective sleep characteristics and continuous glucose monitoring profiles of type 2 diabetes patients in real-life settingsYan Zhao, Yuchan Zheng, Yixin Tian, et al.
Diabetes, Obesity & Metabolism|December 14, 2022
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studiesIldiko Lingvay, Alice Yy Cheng, Joshua A Levine, et al.
Diabetes, Obesity & Metabolism|July 6, 2022
Predictors of time in target glucose range in real-world users of the MiniMed 780G systemJavier Castañeda, Chantal Mathieu, Henk-Jan Aanstoot, et al.
Diabetes, Obesity & Metabolism|July 6, 2022
Disease heterogeneity of adult diabetes based on routine clinical variables at diagnosis: Results from the German/Austrian Diabetes Follow-up RegistryJulia M Grimsmann, Sascha R Tittel, Peter Bramlage, et al.
Diabetes, Obesity & Metabolism|July 6, 2022
Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes: A 24-week, multi-centre, randomized, double-blind, placebo-controlled, superiority, phase III clinical trialJianping Xu, Hongwei Ling, Jianlin Geng, et al.
Diabetes, Obesity & Metabolism|October 7, 2020
Is routine measurement of the serum C-reactive protein level helpful during antibiotic therapy for diabetic foot infection?Truong-Thanh Pham, Oliver Wetzel, Karim Gariani, et al.
Diabetes, Obesity & Metabolism|April 1, 2020
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trialSubodh Verma, Abhinav Sharma, Bernard Zinman, et al.
Diabetes, Obesity & Metabolism|July 12, 2021
Metabolically healthy obesity and cardiovascular events: A nationwide cohort studyGrégoire Fauchier, Arnaud Bisson, Alexandre Bodin, et al.
Diabetes, Obesity & Metabolism|July 15, 2021
Licogliflozin versus placebo in women with polycystic ovary syndrome: A randomized, double-blind, phase 2 trialSusanne Tan, Stanislav Ignatenko, Frank Wagner, et al.
Diabetes, Obesity & Metabolism|July 6, 2021
Impact of SGLT2 inhibitors in comparison with DPP4 inhibitors on ascites and death in veterans with cirrhosis on metforminSaad Saffo, David E Kaplan, Nadim Mahmud, et al.
Pageof 622